Navigation Links
Chris Elliott Fund Comments on Support of Project Violet Initiatives

Seattle, WA (PRWEB) September 05, 2013

On August 29th, Dellann Elliott Mydland of the Chris Elliott Fund released a statement on their support of the initiatives of Project Violet:

"In the 12 years that Chris Elliott Fund has provided patient support to the brain cancer community, we’ve seen how vital the development of new and innovative treatments is to patients diagnosed with brain cancer. Supporting brain cancer research is and will continue to be huge part of our mission and that is why we support Project Violet."

"We identify this as a once in a lifetime opportunity to finally discover a treatment for brain cancer and save lives. We understand that research programs require the need for resources that cannot be raised by any single individual. And we simply cannot allow such an important research program to end due to financial constraint."

"Through Project Violet, the public has a rare opportunity to not only fund research that could help brain tumor patients but to have a seat at the table and share in the triumph and challenges of science from initial research stages through to FDA approval. Chris Elliott Fund in, support of Project Violet, is asking any of those to help."

"We encourage all to join us in supporting Project Violet by watching Dr. Olson’s recent TEDxSeattle talk video at, each video view will result in a $10 donation (of up to $50,000) made by the Washington Research Foundation (WRF), an organization that supports ground breaking research to Project Violet."

"We encourage you to take this opportunity to play a role in finding a cure and help provide hope to the many people inflicted by this devastating disease." - Dellann Elliott Mydland, Founder and President Chris Elliott Fund

About Project Violet:

Project Violet is a collaborative project between researchers from the University of Washington. Researchers Jim Olson, M.D., PhD Patrick Paddison, M.D. have discovered two new drug targets for glioblastoma – BUB1B and PHF5a. In a recent statement, Dr. Olson stated, “these targets, when knocked down, kill glioblastoma cells but not normal brain cells and we think that an effective drug against either would benefit brain cancer patient.”

About the Chris Elliott Fund:

The Chris Elliott Fund (CEF) is a brain cancer and brain tumor patient advocacy organization and national 501(c)(3) non-profit with corporate offices in Seattle, Washington. Established in 2002, Chris Elliott Fund’s mission is to end brain cancer by expanding patient access to specialists, advanced treatments and comprehensive support programs. The organization and its advocates directly serves 400+ patients and caregivers every month free of charge. CEF is a member of the Society for Neurooncologists, American Association of Neuroscience Nurses, American Cancer Association for Cancer Research, Washington Biosciences Association, among others. If we can help, please contact us at WeCare(at)EndBrainCancer(dot)com.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Actors, Models and Talent for Christ (AMTC) Will Hold Cincinnati Auditions for Up and Coming Talent on September 14th, 2013.
2. Chris Holt Joins VHA as Senior Vice President and Executive Officer of Upper Midwest Region
3. Actors, Models and Talent for Christ to Host Auditions at 2pm Only on September 7th to Find Local Atlanta Talent
4. Austen Williams, Mrs. Texas and Alumna from Actors, Models and Talent for Christ (AMTC) Wins The Mrs. America 2013 Title in Pageant Finale Last Night, August 28th
5. Corpus Christi, TX Gum Disease Prevention and Treatment in Pregnant Women is Now Possible with Laser Gum Disease Treatment from Dr. Tilman Richards
6. Christian Meditation Techniques
7. “Best Of Christian Meditation And Relaxation” Helps People Get Rid Of Negative Thinking and Stress Easily – V kool
8. African Ambassador Christen the Spirit of Malabo in New York City
9. On September 14th, Actors, Models and Talent for Christ Will Hold Cincinnati Auditions for Up and Coming Talent of All Ages
10. Jenn Gotzon, Scout, Mentor and Acting Teacher for Actors, Models and Talent for Christ is Hosting Omaha, Nebraska Auditions on September 14, 2013
11. Christine Fleming named to MIT Technology Reviews annual Innovators Under 35 list
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: